Cocrystal Pharma (COCP) Profit After Tax (2010 - 2026)

Cocrystal Pharma (COCP) has 17 years of Profit After Tax data on file, last reported at -$2.3 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax changed 0.09% year-over-year to -$2.3 million; the trailing twelve-month figure through Mar 2026 stood at -$8.8 million (up 44.49% YoY), and the FY2025 full-year result was -$8.8 million, up 49.73% from the prior year.
• Profit After Tax improved to -$2.3 million in Q1 2026, from -$2.4 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$2.0 million in Q3 2025 to a low of -$24.4 million in Q2 2022.
• A 5-year average of -$5.0 million and a median of -$4.2 million in 2023 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax sank 539.31% in 2022 and soared 82.95% in 2023, its largest moves.
• Tracing COCP's Profit After Tax over 5 years: stood at -$4.5 million in 2022, then gained by 0.82% to -$4.5 million in 2023, then climbed by 26.84% to -$3.3 million in 2024, then gained by 26.67% to -$2.4 million in 2025, then increased by 4.01% to -$2.3 million in 2026.
• Business Quant data shows COCP's Profit After Tax at -$2.3 million in Q1 2026, -$2.4 million in Q4 2025, and -$2.0 million in Q3 2025.